image
The Oncology Institute, Inc. TOIIW
Healthcare - Medical - Care Facilities - NASDAQ - US
Watchlist
$ 0.0615
2.5 %
$ 220 M
Market Cap
None
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 22, 2025.

The intrinsic value of one TOIIW stock under the worst case scenario is HIDDEN Compared to the current market price of 0.0615 USD, The Oncology Institute, Inc. is HIDDEN

TOIIW Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jun, 22, 2025.

The intrinsic value of one TOIIW stock under the base case scenario is HIDDEN Compared to the current market price of 0.0615 USD, The Oncology Institute, Inc. is HIDDEN

TOIIW Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jun, 22, 2025.

The intrinsic value of one TOIIW stock under the best case scenario is HIDDEN Compared to the current market price of 0.0615 USD, The Oncology Institute, Inc. is HIDDEN

TOIIW Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart TOIIW

image
1M -13%
6M 464.0%
1Y 232.0%
3Y -713%
5Y -2176%
All
$0.2$0.2$0.2$0.2$0.1$0.1$0.1$0.1$0.1$0.1$0.1$0.1$0.1$0.1$0.0$0.0$0.0$0.0$0.0$0.0Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25
FINANCIALS
393 M REVENUE
21.33%
Growth Rates
1Year 21.33%
3Years 24.68%
5Years 20.41%
7Years 0.00%
10Years 0.00%
-60.1 M OPERATING INCOME
21.94%
Growth Rates
1Year 21.94%
3Years -9.45%
5Years -86.92%
7Years 0.00%
10Years 0.00%
-64.7 M NET INCOME
22.16%
Growth Rates
1Year 22.16%
3Years -80.88%
5Years -74.28%
7Years 0.00%
10Years 0.00%
-26.5 M OPERATING CASH FLOW
26.92%
Growth Rates
1Year 26.92%
3Years 6.70%
5Years -52.84%
7Years 0.00%
10Years 0.00%
46.2 M INVESTING CASH FLOW
-26.23%
Growth Rates
1Year -26.23%
3Years 79.69%
5Years 109.51%
7Years 0.00%
10Years 0.00%
-3.49 M FINANCING CASH FLOW
49.00%
Growth Rates
1Year 49.00%
3Years -0.75%
5Years -353.82%
7Years 0.00%
10Years 0.00%
104 M REVENUE
4.13%
Growth Rates
1Year 21.33%
3Years 24.68%
5Years 20.41%
7Years 0.00%
10Years 0.00%
-9.91 M OPERATING INCOME
16.92%
Growth Rates
1Year 21.94%
3Years -9.45%
5Years -86.92%
7Years 0.00%
10Years 0.00%
-19.6 M NET INCOME
-48.57%
Growth Rates
1Year 22.16%
3Years -80.88%
5Years -74.28%
7Years 0.00%
10Years 0.00%
-4.99 M OPERATING CASH FLOW
-119.16%
Growth Rates
1Year 26.92%
3Years 6.70%
5Years -52.84%
7Years 0.00%
10Years 0.00%
-202 K INVESTING CASH FLOW
88.49%
Growth Rates
1Year -26.23%
3Years 79.69%
5Years 109.51%
7Years 0.00%
10Years 0.00%
-4.74 M FINANCING CASH FLOW
-2790.24%
Growth Rates
1Year 49.00%
3Years -0.75%
5Years -353.82%
7Years 0.00%
10Years 0.00%
Balance Sheet The Oncology Institute, Inc.
image
Current Assets 112 M
Cash & Short-Term Investments 49.7 M
Receivables 48.7 M
Other Current Assets 14.1 M
Non-Current Assets 60.3 M
Long-Term Investments 0
PP&E 37.7 M
Other Non-Current Assets 22.6 M
28.76 %28.19 %8.15 %21.81 %13.10 %Total Assets$172.7m
Current Liabilities 52.2 M
Accounts Payable 24.3 M
Short-Term Debt 6.8 M
Other Current Liabilities 21.1 M
Non-Current Liabilities 117 M
Long-Term Debt 116 M
Other Non-Current Liabilities 559 K
14.38 %4.02 %12.47 %68.80 %Total Liabilities$169.1m
EFFICIENCY
Earnings Waterfall The Oncology Institute, Inc.
image
Revenue 393 M
Cost Of Revenue 339 M
Gross Profit 54 M
Operating Expenses 114 M
Operating Income -60.1 M
Other Expenses 4.54 M
Net Income -64.7 M
400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)393m(339m)54m(114m)(60m)(5m)(65m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
13.73% GROSS MARGIN
13.73%
Averages
1Year 13.73%
3Years 17.58%
5Years 18.50%
7Years 19.29%
10Years 0.00%
-15.28% OPERATING MARGIN
-15.28%
Averages
1Year -15.28%
3Years -22.52%
5Years -18.90%
7Years -13.14%
10Years 0.00%
-16.44% NET MARGIN
-16.44%
Averages
1Year -16.44%
3Years -13.80%
5Years -10.88%
7Years -7.65%
10Years 0.00%
-1801.70% ROE
-1801.70%
Averages
1Year -1801.70%
3Years -648.68%
5Years -401.50%
7Years -288.15%
10Years 0.00%
-37.44% ROA
-37.44%
Averages
1Year -37.44%
3Years -25.50%
5Years -20.74%
7Years -15.78%
10Years 0.00%
-44.83% ROIC
-44.83%
Averages
1Year -44.83%
3Years -37.86%
5Years -31.42%
7Years -23.69%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis The Oncology Institute, Inc.
image
10m10m00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)20192019202020202021202120222022202320232024202420252025
Net Income -64.7 M
Depreciation & Amortization 6.29 M
Capital Expenditures -3.79 M
Stock-Based Compensation 11.2 M
Change in Working Capital 18.1 M
Others 13.6 M
Free Cash Flow -30.3 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets The Oncology Institute, Inc.
image
TOIIW has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 3 of 2
6. Ownership
Insider Ownership The Oncology Institute, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
8. Profile Summary

The Oncology Institute, Inc. TOIIW

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 220 M
Dividend Yield 0.00%
Description The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients. The company was founded in 2007 and is based in Cerritos, California.
Contact 18000 Studebaker Road, Cerritos, CA, 90703 https://theoncologyinstitute.com
IPO Date None
Employees 825
Officers Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H. Chief Medical Officer Mr. Austin Lee Vice President of Accounting & Controller Dr. Daniel Virnich FACHE, M.B.A., M.D. Chief Executive Officer & Executive Director Mr. Mark Hueppelsheuser Esq. General Counsel Mr. Stephen Cella Senior Vice President of Finance Mr. Richard Alan Barasch Chairman of the Board Mr. Jeremy N. Castle M.B.A. Chief Operations Officer Mr. Jordan McInerney Chief Development Officer Mr. Robert Carter Chief Financial Officer